Menu
View Cart  

Amgen Looks to Replicate Humira, Files Biosimilar Application With FDA

$40.00
Product Description

Related Products

FDA Accepts Sandoz’s Application for Biosimilar of Amgen’s Enbrel

Hospira Prepares Second Biosimilar Application After FDA Rejects First

FDA Accepts Apotex’s Pegfilgrastim Application as Biosimilars Movement Slowly Gains Steam

Search the Store

Shop by Category

Shop by Media